Novotny Laura A, Jurcisek Joseph A, Godfroid Fabrice, Poolman Jan T, Denoël Philippe A, Bakaletz Lauren O
Columbus Children's Research Institute, Center for Microbial Pathogenesis, The Ohio State University College of Medicine and Public Health, 700 Children's Drive, W591, 43205, USA.
Vaccine. 2006 May 29;24(22):4804-11. doi: 10.1016/j.vaccine.2006.03.021. Epub 2006 Mar 27.
Passive transfer of a pediatric human serum pool generated against polysaccharide-protein D conjugate vaccines conferred approximately 34% protection against development of ascending NTHI-induced OM when used in a chinchilla viral-bacterial co-infection model. These data are in line with results obtained using a similar 11-valent-protein D conjugate vaccine in a pediatric clinical trial, wherein a vaccine efficacy of 35.6% was shown against acute OM episodes caused by NTHI. These observations strongly support the chinchilla passive transfer-superinfection model as one that could predict clinical trials outcomes for vaccines to prevent NTHI-induced OM.
在栗鼠病毒-细菌共感染模型中,使用针对多糖-蛋白D结合疫苗产生的儿科人血清库进行被动转移,可对上行性NTHI诱导的中耳炎的发生提供约34%的保护。这些数据与在儿科临床试验中使用类似的11价蛋白D结合疫苗所获得的结果一致,该试验显示针对由NTHI引起的急性中耳炎发作的疫苗效力为35.6%。这些观察结果有力地支持了栗鼠被动转移-重复感染模型可作为预测预防NTHI诱导的中耳炎疫苗临床试验结果的模型。